Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01438710 · ClinicalTrials.gov registry record · Phase 3
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
A Phase 3 study, sponsored by Veloxis Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
NCT01438710 is a Phase 3 study that has completed, run by Veloxis Pharmaceuticals. The registered enrollment target is 44 participants.
The verdict
NCT01438710, a Phase 3 study, has completed, sponsored by Veloxis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study will evaluate and measure symptomatic hand tremor in stable kidney transplant subjects on Prograf or generic tacrolimus maintenance therapy at baseline (pre-conversion) and following conversion to LCP-Tacro. This study will also evaluate the safety of LCP-Tacro compared with Prograf or generic tacrolimus
Interventions
- DRUG LCP-Tacro
- DRUG Prograf
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01438710
The ClinicalTrials.gov registry entry for NCT01438710 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veloxis Pharmaceuticals, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LCP-Tacro is the first listed.
NCT01438710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01438710 about?
NCT01438710 is a clinical study titled "Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)". This study will evaluate and measure symptomatic hand tremor in stable kidney transplant subjects on Prograf or generic tacrolimus maintenance therapy at baseline (pre-conversion) and following conversion to LCP-Tacro. This study will also evaluate the safety of LCP-Tacro compared with Prograf or ge...
What is the current status of trial NCT01438710?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2011-12. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01438710?
The interventions under investigation include: LCP-Tacro (DRUG), Prograf (DRUG).
Who is sponsoring clinical trial NCT01438710?
This trial is sponsored by Veloxis Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.